[ HOW-TO GUIDE ]

How to Respond to an FDA 483

Write a Form FDA 483 response FDA can rely on — inside the 15 business days.

What a how-to is not

A how-to is SPEQ’s practitioner method, not a procedure. It does not replace your own SOP, it is not a validated approach, and the judgement calls in it belong to your quality unit.

A Form FDA 483 is not FDA’s final decision, and the response is the firm’s best chance to shape what happens next. FDA’s 2009 program and the 2026 IOM both say an adequate response within 15 business days may affect whether further action follows. This is how to build one that answers the observation, the system behind it, and the factors FDA says it weighs.

WORK THROUGH THESE STEPS IN THE TEMPLATE
FDA 483 and Warning Letter Response
Each step below has a place in SPEQ’s structured, regulator-aligned template for this procedure. Open the template →
THE STEPS
  1. 1

    Start the clock at close-out

    The 15 business days run from the end of the inspection, the day the 483 is issued. Name the response owner and team that day, and agree who signs: the response should come from management that can commit resources.

  2. 2

    Scope each observation beyond the sample

    An observation is written against a population — “2 of 50 records examined”. Find out how many records, batches, products, lines and sites the same system touches, and say so. FDA’s Regulatory Procedures Manual asks whether a correction covers related violations and related products or facilities.

  3. 3

    Find the root cause

    Investigate to a systemic cause you can act on. “Human error” with retraining as the only action rarely satisfies anyone, because it changes nothing about why the error was possible.

  4. 4

    Answer each observation in the same structure

    Restate the observation verbatim, then give the investigation and its scope, the root cause, the correction of the specific instances, the systemic corrective and preventive action, owners and dates, and how effectiveness will be checked. Keep the order identical for every observation so a reviewer can compare them.

  5. 5

    Prove what is done, commit only to what will be done

    Attach evidence for every completed action — revised procedures, training records, data, photographs. For open actions give dates the organisation has agreed. FDA weighs whether documentation was provided, whether the timeframe is appropriate and whether progress is real.

  6. 6

    Submit on time, then keep reporting

    Submit within the 15 business days, then send progress updates on open commitments until each is complete. A timely response is reviewed in detail before any warning-letter decision; a late one is not routinely addressed in a warning letter.

COMMON PITFALLS
  • !Answering the two records in the observation and not the system that produced them.
  • !Promises without evidence: ongoing or promised corrective actions generally do not prevent a warning letter.
  • !Several piecemeal responses over months instead of one complete response and planned updates.
  • !Disputing an observation without evidence — or conceding one that is factually wrong instead of explaining why.
REGULATORY BASIS
GO DEEPER

How to Respond to an FDA 483: frequently asked questions

Common questions on respond to an fda 483.

Is the 15-business-day deadline a legal requirement?

No. Responding is voluntary. The 15 business days come from FDA’s 2009 program on post-inspection responses (74 FR 40211) and are repeated in the 2026 IOM: a response received in that window is reviewed in detail before FDA decides whether to issue a warning letter.

Does a good response guarantee no warning letter?

No. FDA may issue a warning letter at any time, and promised corrections generally do not prevent one. Where FDA concludes that completed corrections are adequate and the violations corrected, its Regulatory Procedures Manual says a warning letter generally should not be issued.

For a device 483, can we get FDA feedback on our plan?

Section 704(h)(2) lets a device establishment make a timely request for nonbinding FDA feedback, within 45 days, on actions it proposes in response to a 483 that involve a public health priority, systemic or major actions, or emerging safety issues, as FDA determines.

RELATED HOW-TO GUIDES
All 127 guides →

WHERE NEXT

  1. DO ITOpen the FDA 483 and Warning Letter Response template →The structure these steps fill in.
  2. UNDERSTAND ITResponding to an FDA 483 and a Warning Letter →The principles behind the procedure.
  3. ALL GUIDESBrowse all 127 how-to guides →

A free account keeps what you save, remembers where you are across devices, and can send you the weekly regulatory briefing. Create a free account